Combination Therapy of Laser Plus VANIQA for Treatment of Unwanted Facial Hair Provides Women With Quicker and More Complete Results; Clinical Data Presented at American Academy of Dermatology's 63rd Annual Meeting.
From: PR Newswire
NEW ORLEANS, Feb. 18 /PRNewswire/ -- SkinMedica, Inc., a specialty pharmaceutical company developing and marketing dermatology products, announced today results of two clinical studies that found the combination of laser hair removal with eflornithine HCL 13.9 cream (VANIQA(R)) to be a more compelling treatment for unwanted facial hair in women than laser hair removal alone. Dr. Valerie Callender and Dr. Michael Gold will each present their findings at the 63rd Annual American Academy of Dermatology (AAD) meeting this weekend. VANIQA, a topical prescription cream, is the only ...
About Our Articles: We've partnered with Highbeam Research to provide these article excerpts for your research needs. However, due to copyright laws, we cannot publish the whole article. To view these articles in full length you'll need to use the link above to access the free trial at Highbeam.